These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11518127)

  • 1. Acute interstitial pneumonia induced by ONO-1078 (pranlukast), a leukotriene receptor antagonist.
    Takahashi N; Iwanaga T; Aizawa H; Koto H; Watanabe K; Kishikawa R; Ikeda T; Shoji S; Nishima S; Hara N
    Intern Med; 2001 Aug; 40(8):791-4. PubMed ID: 11518127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Churg-Strauss syndrome after corticosteroid withdrawal in an asthmatic patient treated with pranlukast.
    Kinoshita M; Shiraishi T; Koga T; Ayabe M; Rikimaru T; Oizumi K
    J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):534-5. PubMed ID: 10069892
    [No Abstract]   [Full Text] [Related]  

  • 3. Churg-Strauss syndrome and the leukotriene receptor antagonist pranlukast.
    Shimbo J; Onodera O; Tanaka K; Tsuji S
    Clin Rheumatol; 2005 Nov; 24(6):661-2. PubMed ID: 15578247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of the leukotriene receptor antagonist pranlukast versus the steroid inhalant fluticasone in the therapy of aged patients with mild bronchial asthma.
    Horiguchi T; Tachikawa S; Kondo R; Miyazaki J; Shiga M; Hirose M; Kobayashi K; Hayashi N; Ohira D; Nasu T; Otake Y; Hata H
    Arzneimittelforschung; 2007; 57(2):87-91. PubMed ID: 17396618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of the first U.S. double-blind, placebo-controlled, multicenter clinical study in asthma with pranlukast, a novel leukotriene receptor antagonist.
    Grossman J; Faiferman I; Dubb JW; Tompson DJ; Busse W; Bronsky E; Montanaro A; Southern L; Tinkelman D
    J Asthma; 1997; 34(4):321-8. PubMed ID: 9250256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Churg-Strauss syndrome after reduction of inhaled corticosteroid in a patient treated with pranlukast for asthma.
    Hashimoto M; Fujishima T; Tanaka H; Kon H; Saikai T; Suzuki A; Nakatsugawa M; Abe S
    Intern Med; 2001 May; 40(5):432-4. PubMed ID: 11393418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Churg-Strauss syndrome during corticosteroid tapering in a patient with bronchial asthma receiving pranlukast].
    Baba K; Niwa S; Yagi T; Sakakibara A; Kobayashi T; Matsumoto Y
    Arerugi; 2000 Jun; 49(6):512-5. PubMed ID: 10916890
    [No Abstract]   [Full Text] [Related]  

  • 8. Pranlukast, a novel leukotriene receptor antagonist: results of the first European, placebo controlled, multicentre clinical study in asthma.
    Barnes NC; Pujet JC
    Thorax; 1997 Jun; 52(6):523-7. PubMed ID: 9227718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized controlled phase II clinical trial comparing ONO-4053, a novel DP1 antagonist, with a leukotriene receptor antagonist pranlukast in patients with seasonal allergic rhinitis.
    Okubo K; Hashiguchi K; Takeda T; Baba K; Kitagoh H; Miho H; Tomomatsu H; Yamaguchi S; Odani M; Yamamotoya H
    Allergy; 2017 Oct; 72(10):1565-1575. PubMed ID: 28378369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Churg-Strauss syndrome after pranlukast treatment in a patient not receiving corticosteroids.
    Katsura T; Yoshida F; Takinishi Y
    Ann Intern Med; 2003 Sep; 139(5 Pt 1):386-7. PubMed ID: 12965953
    [No Abstract]   [Full Text] [Related]  

  • 11. Worldwide clinical experience with the first marketed leukotriene receptor antagonist.
    Barnes NC; de Jong B; Miyamoto T
    Chest; 1997 Feb; 111(2 Suppl):52S-60S. PubMed ID: 9042027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of switching low-dose inhaled corticosteroid to pranlukast for step-down therapy in well-controlled patients with mild persistent asthma.
    Harada S; Harada N; Itoigawa Y; Katsura Y; Kasuga F; Ishimori A; Makino F; Ito J; Atsuta R; Takahashi K
    J Asthma; 2016; 53(2):207-12. PubMed ID: 26325232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of pranlukast, a cysteinyl leukotriene receptor 1 antagonist, combined with inhaled beclomethasone in patients with moderate or severe asthma.
    Tomari S; Shimoda T; Kawano T; Mitsuta K; Obase Y; Fukushima C; Matsuse H; Kohno S
    Ann Allergy Asthma Immunol; 2001 Aug; 87(2):156-61. PubMed ID: 11527250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tubulointerstitial nephritis induced by the leukotriene receptor antagonist pranlukast.
    Schurman SJ; Alderman JM; Massanari M; Lacson AG; Perlman SA
    Chest; 1998 Oct; 114(4):1220-3. PubMed ID: 9792602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cough-variant asthma successfully treated with a peptide leukotriene receptor antagonist].
    Nishi K; Watanabe K; Ooka T; Fujimura M; Matsuda T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Jan; 35(1):117-23. PubMed ID: 9071168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delay of onset of symptoms of Japanese cedar pollinosis by treatment with a leukotriene receptor antagonist.
    Gotoh M; Suzuki H; Okubo K
    Allergol Int; 2011 Dec; 60(4):483-9. PubMed ID: 21778814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pranlukast, a leukotriene receptor antagonist, in patients with severe asthma refractory to corticosteroids.
    Yokoyama A; Kohno N; Sakai K; Hirasawa Y; Kondo K; Hiwada K
    J Asthma; 1998; 35(1):57-62. PubMed ID: 9513583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fulminant eosinophilic endomyocarditis in an asthmatic patient treated with pranlukast after corticosteroid withdrawal.
    Hayashi S; Furuya S; Imamura H
    Heart; 2001 Sep; 86(3):E7. PubMed ID: 11514498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of a leukotriene antagonist, pranlukast hydrate, on exercise-induced asthma for 14 days].
    Suguro H; Majima T; Hattori T; Ichimura K; Hashimoto N; Horie T
    Arerugi; 2000 Aug; 49(8):646-52. PubMed ID: 11021016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of regular treatment with inhaled corticosteroid or leukotriene receptor antagonist in mild intermittent asthma.
    Tamaoki J; Isono K; Taira M; Tagaya E; Nakata J; Kawatani K; Nagai A
    Allergy Asthma Proc; 2008; 29(2):189-96. PubMed ID: 18430318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.